ILMN vs VIR · rev $2.25B vs rev $238.9M
Illumina Inc (ILMN) versus Vir Biotechnology Inc (VIR) — a side-by-side from cached financials, not a winner call.
Illumina Inc (ILMN) is a diagnostics & research company listed on US.
Vir Biotechnology Inc (VIR) is a biotechnology company listed on NASDAQ.
Latest reported ILMN revenue for 2026-06-28 was $2.25B. Net income was $340.0M. ILMN currently screens at market cap $15.84B.
Latest reported VIR revenue for 2026-06-30 was $238.9M. Net income was -$45.6M. VIR currently screens at market cap $1.45B.
ILMN currently screens at market cap $15.84B. VIR currently screens at market cap $1.45B.
Not investment advice. Open the ILMN and VIR stock pages for the full models.
Not investment advice.